What is the ticker symbol for Qualigen Therapeutics?

Qualigen Therapeutics trades under the ticker QLGN on NASDAQ.

What sector does Qualigen Therapeutics operate in?

Qualigen Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze QLGN in a portfolio?

PortView shows QLGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Qualigen Therapeutics (QLGN) Stock Analysis

NASDAQHealthcareBiotechnology

$3.21+5.59%

1-year price historyRange $1.67 – $6.01

52-week range$3.21

$1.61$8.81

What Qualigen Therapeutics does

Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.

Key metrics

Market cap

$5.43M

P/E (TTM)

1.13

EPS (TTM)

$2.85

Beta

0.28

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$3.63

200-day avg

$3.20

52-week high

$8.81

52-week low

$1.61

CEO

Kevin A. Richardson II

ETFs linked to QLGN

Broad-market and Healthcare sector ETFs an investor holding Qualigen Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how QLGN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze QLGN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Qualigen Therapeutics?: Qualigen Therapeutics trades under the ticker QLGN on NASDAQ.
Which exchange is QLGN listed on?: QLGN is listed on NASDAQ.
What sector does Qualigen Therapeutics operate in?: Qualigen Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze QLGN in a portfolio?: PortView shows QLGN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.